Identification of methylated genes associated with aggressive bladder cancer. - Wikidata - awgldk - TriplyDB

Identification of methylated genes associated with aggressive bladder cancer.

Identification of methylated genes associated with aggressive bladder cancer.

http://www.wikidata.org/entity/Q33680247

about

Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise DNA methylation changes in the placenta are associated with fetal manganese exposure Epigenomic characterization of locally advanced anal cancer: a radiation therapy oncology group 98-11 specimen study The influence of aging, environmental exposures and local sequence features on the variation of DNA methylation in blood Methylation and loss of Secreted Frizzled-Related Protein 3 enhances melanoma cell migration and invasion Developmental genes targeted for epigenetic variation between twin-twin transfusion syndrome children.A global profile of gene promoter methylation in treatment-naïve urothelial cancer IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status A systematic analysis on DNA methylation and the expression of both mRNA and microRNA in bladder cancer DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer.Epigenetic alterations in metastatic cutaneous carcinoma.Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology.Association of secondhand smoke exposures with DNA methylation in bladder carcinomas.Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas.Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.A functional in vivo screen for regulators of tumor progression identifies HOXB2 as a regulator of tumor growth in breast cancer Epigenetic alterations of the keratin 13 gene in oral squamous cell carcinoma.Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers The long noncoding RNA HOTAIR has tissue and cell type-dependent effects on HOX gene expression and phenotype of urothelial cancer cells.In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta.Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence Combined RASSF1A and RASSF2A Promoter Methylation Analysis as Diagnostic Biomarker for Bladder Cancer.DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status Subcutaneous 5-azacitidine treatment of naturally occurring canine urothelial carcinoma: a novel epigenetic approach to human urothelial carcinoma drug development.Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.MTHFR C677T polymorphisms are associated with aberrant methylation of the IGF-2 gene in transitional cell carcinoma of the bladder Identification and characterization of genes that control fat deposition in chickens.Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer Hypomethylating agents for urologic cancers.A current global view of environmental and occupational cancers.Global epigenetic profiling in bladder cancer.Hypermethylation in bladder cancer: biological pathways and translational applications.Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.DNA methylation-based biomarkers in bladder cancer.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Noninvasive approaches for detecting and monitoring bladder cancer.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.

P2860

Q26775990-FF8161AF-72F0-48A4-B41F-EACF8BC21C10 Q28386818-6388CF9C-E955-4AB4-8609-11EA07B172F3 Q28390359-BDA21A8C-ECCA-4019-A8BA-BBDA1A1DBF76 Q28391041-77225222-95D0-40BA-9D63-E66C9DC87AB2 Q28741295-A3C98303-CB8A-47F8-8C22-69624DA25587 Q33590312-23250520-148E-4CF6-83C9-89A3A8CE09FE Q33779194-7640CB27-C5B0-4CA3-9C96-781834D8F7E9 Q33992811-2F4554F9-AFC2-465D-904A-FC564017947A Q34091387-0AF265EC-2853-4A5C-AB86-AFB80A35B640 Q34253377-F9D39307-635D-4F91-92D7-FBC86F0DDB79 Q34283143-482D72DF-EC38-4B4B-AE27-83048FDB746B Q35019180-0DFB7F4A-B62F-4267-ADF8-915A3340E678 Q35118861-284052C2-E7BA-42FB-8799-00B8EDE5A579 Q35159055-B23EF6D1-77C9-4F05-9218-9DA449FD6574 Q35178079-13EC933B-9CA6-4723-A683-FFD31240DD1C Q35190545-1B825E5C-C478-4BD2-9C41-73E2459E8784 Q35191504-F4778098-E4C9-42EE-8C4C-8EF94E88D7E9 Q35592187-A8CEA4B0-5DF2-483F-8766-BBDFE4C37321 Q35624169-CCB4BFB0-044B-4143-ABA3-4688F48F646D Q35683471-A303638B-F7C9-41FE-95E8-55D74CCC65DB Q35756857-3B5FD94A-9DDB-44AB-A2F6-5FDFB77E51BE Q35799910-51E62441-D051-4FF9-96DC-6C2AB0DA2BE4 Q35864106-6C8A6BAA-7D8F-4841-848B-EDC645E0A9CF Q35888926-08579529-54F5-4779-9D29-11A8A498D066 Q36187834-9E46D636-FC0A-4868-B467-9B1285138A07 Q36430196-91A08679-967C-4BD0-8F55-D432B4CDAD2C Q36589155-84CE349C-4C4F-4E4D-B224-D8C1BB64E9E8 Q36684066-A42EE000-6FBB-4713-93FE-C66016009175 Q37418060-94E05328-19B5-45D5-B587-FED93A8CC2C0 Q37627004-E9705F01-D9A2-4914-AFE5-102DDB388A99 Q37854737-A5D2D679-3FCA-474A-8B30-0C5E0755777B Q37935012-8244659C-6304-4703-98DF-56F9867D422B Q37962571-55407E16-417B-4D8D-BC42-0765AB514108 Q37978544-EE9814D1-74F8-4F6B-AF23-577BF4B36F1F Q38068225-9D3265CB-A6CD-40A7-8DE4-070CCF1CC2C9 Q38102879-052E60FA-FA7C-49A3-BAC5-45EAD96EB176 Q38216129-9DF7171B-AC97-47BE-A957-ADB4CA811A5E Q38286089-5B577C6D-353F-40D2-AF32-F6B4552E1482 Q38297729-7B687D0C-772D-4422-9B38-556D138836AD Q38833395-DF630DA0-5056-4544-8ABA-4ADDC3A639F2

P2860

Identification of methylated genes associated with aggressive bladder cancer.

http://www.wikidata.org/entity/Q33680247

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Identification of methylated genes associated with aggressive bladder cancer.

@ast

Identification of methylated genes associated with aggressive bladder cancer.

@en

type

label

Identification of methylated genes associated with aggressive bladder cancer.

@ast

Identification of methylated genes associated with aggressive bladder cancer.

@en

prefLabel

Identification of methylated genes associated with aggressive bladder cancer.

@ast

Identification of methylated genes associated with aggressive bladder cancer.

@en

P1433

Q33680247-A5CA86B1-BF57-4C89-9B25-BBFB4A2804B0

P1476

Q33680247-A6A79F01-4C7A-4791-8769-2CB1E71A6430

P2093

Q33680247-16BC123A-99DB-4579-B9E6-6539B34B76E9

Q33680247-2C71096E-ED66-4A62-B709-E3A87FC4321B

Q33680247-2E01EBBF-9A08-4A6A-954C-31282515E5FD

Q33680247-461B00B8-6414-41B7-A5D0-D7D147D47CE4

Q33680247-A4775492-B06A-454E-B9B5-470DBCF18A3E

Q33680247-A907048F-840D-4423-A96D-A1A7DFE3C851

Q33680247-B6D69066-C361-4CD6-BCCA-BD3DA2E91715

Q33680247-C81D72BB-FCE4-4FDC-B876-C38940E834BC

Q33680247-ED2F41DB-ABFA-4EFD-A627-5A0EAF10F1B9

Q33680247-F2117D4A-C303-457E-8A6C-865ED95D30D4

P2860

Q33680247-0030DEC2-3595-469F-9046-411EF2667E24

Q33680247-05B7A764-2516-4A10-9C30-1A76BF93B20F

Q33680247-0A65ABD2-CDD9-4578-93DA-919E38108C5F

Q33680247-11119214-1606-44C4-AF8D-D4DF17A43054

Q33680247-1C95BE3F-C774-4BC2-95AC-4EFCD8CD3217

Q33680247-23D11178-CA72-48FC-B4FF-C1704D12D554

Q33680247-2785223B-B08F-41F4-B047-D081410C3F28

Q33680247-2903A3F4-6AB4-49F2-9717-203134DA1FEA

Q33680247-2D803151-B6A0-47AB-ADBE-4882F23C1BB2

Q33680247-302BC14C-CEFB-44DB-8B21-689FB92DC025

P304

Q33680247-BCED8D0E-6510-437A-8F4B-A4AAA3876D11

P31

Q33680247-7C020166-A5EB-4437-BE02-2FD890657078

P356

Q33680247-3E2F2F81-6D2C-4E5D-8EA5-C98FE58F279C

P407

Q33680247-E3A6F671-18D5-4B29-82B9-05E38CA065DB

P433

Q33680247-46E72EAC-FED3-41EF-9872-C95FADC0D40F

P478

Q33680247-551BF772-4218-4D7C-BAC6-2CF459C92172

P50

Q33680247-5F3FB23A-D1FF-4EF1-A897-191CFFF9307F

Q33680247-B856CC9E-FCE3-4928-A863-52A2CDBE891E

Q33680247-EE2F467F-D4DA-461F-B309-D91871922ABE

P577

Q33680247-93E512B9-8C6F-408E-96C0-D511FB27F740

P5875

Q33680247-6DB597BD-C193-4E3B-8631-599CFE1CEE8B

P698

Q33680247-2D247613-4C4B-4E20-ABC1-B8301AFE0E87

P932

Q33680247-1A49E56D-31C7-4AF9-98A9-EAD44D565BB5

P356

JOURNAL.PONE.0012334

P1433

P1476

Identification of methylated genes associated with aggressive bladder cancer.

@en

P2093

Alan R Schned

http://www.w3.org/2001/XMLSchema#string

Angeline S Andrew

http://www.w3.org/2001/XMLSchema#string

Brock C Christensen

http://www.w3.org/2001/XMLSchema#string

E Andres Houseman

http://www.w3.org/2001/XMLSchema#string

John K Wiencke

http://www.w3.org/2001/XMLSchema#string

Joseph Wiemels

http://www.w3.org/2001/XMLSchema#string

Karl T Kelsey

http://www.w3.org/2001/XMLSchema#string

Luc Gagne

http://www.w3.org/2001/XMLSchema#string

Margaret R Karagas

http://www.w3.org/2001/XMLSchema#string

Margaret R Wrensch

http://www.w3.org/2001/XMLSchema#string

P2860

A new mathematical model for relative quantification in real-time RT-PCR

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection

Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome

Cancer statistics, 2009

Chromatin signatures of pluripotent cell lines

Epigenetic stem cell signature in cancer

P304

e12334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0012334

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Heather H. Nelson

P577

2010-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46108547

http://www.w3.org/2001/XMLSchema#string

P698

20808801

http://www.w3.org/2001/XMLSchema#string

P932

2925945

http://www.w3.org/2001/XMLSchema#string